Global Nanopharmaceuticals Supply, Demand and Key Producers, 2024-2030

Description

The global Nanopharmaceuticals market size is expected to reach $ 72390 million by 2030, rising at a market growth of 12.4% CAGR during the forecast period (2024-2030).

USA is the largest Nanopharmaceuticals market with about 59% market share. Europe is follower, accounting for about 33% market share.

The key players are Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Roche, Sanofi, Eli Lilly, Astrazeneca, Johnson & Johnson, Celgene, Novavax, Stryker, Gilead Sciences, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Pharma, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma, Navidea Biopharmaceuticals, Lummy etc. Top 3 companies occupied about 34% market share.

Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their “bulk” counterparts primarily because of size.

There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.

This report studies the global Nanopharmaceuticals production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Nanopharmaceuticals, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nanopharmaceuticals that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Nanopharmaceuticals total production and demand, 2019-2030, (K MT)
Global Nanopharmaceuticals total production value, 2019-2030, (USD Million)
Global Nanopharmaceuticals production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K MT)
Global Nanopharmaceuticals consumption by region & country, CAGR, 2019-2030 & (K MT)
U.S. VS China: Nanopharmaceuticals domestic production, consumption, key domestic manufacturers and share
Global Nanopharmaceuticals production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K MT)
Global Nanopharmaceuticals production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K MT)
Global Nanopharmaceuticals production by Application production, value, CAGR, 2019-2030, (USD Million) & (K MT).

This reports profiles key players in the global Nanopharmaceuticals market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Roche, Sanofi, Eli Lilly and Astrazeneca, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nanopharmaceuticals market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K MT) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Nanopharmaceuticals Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Nanopharmaceuticals Market, Segmentation by Type
    Liposomes
    Polymeric Micelles
    Solid Lipid Nanoparticles
    Microemulsion and Nnanoemulsion
    Nanosuspension

Global Nanopharmaceuticals Market, Segmentation by Application
    Cancer and Tumor
    Autoimmune Disorders
    Inflammation
    Others

Companies Profiled:
    Merck
    Pfizer
    Novartis
    Abbott
    GlaxoSmithKline
    Roche
    Sanofi
    Eli Lilly
    Astrazeneca
    Johnson & Johnson
    Celgene
    Novavax
    Stryker
    Gilead Sciences
    OSI Pharmaceuticals
    Kadmon Pharmaceuticals
    Samyang Biopharm
    Mitsubishi Pharma
    Kaken Pharmaceutical
    Selecta Biosciences
    Par Pharmaceutical
    Cerulean Pharma
    Navidea Biopharmaceuticals
    Lummy

Key Questions Answered
1. How big is the global Nanopharmaceuticals market?
2. What is the demand of the global Nanopharmaceuticals market?
3. What is the year over year growth of the global Nanopharmaceuticals market?
4. What is the production and production value of the global Nanopharmaceuticals market?
5. Who are the key producers in the global Nanopharmaceuticals market?

Table of Contents

1 Supply Summary
    1.1 Nanopharmaceuticals Introduction
    1.2 World Nanopharmaceuticals Supply & Forecast
        1.2.1 World Nanopharmaceuticals Production Value (2019 & 2023 & 2030)
        1.2.2 World Nanopharmaceuticals Production (2019-2030)
        1.2.3 World Nanopharmaceuticals Pricing Trends (2019-2030)
    1.3 World Nanopharmaceuticals Production by Region (Based on Production Site)
        1.3.1 World Nanopharmaceuticals Production Value by Region (2019-2030)
        1.3.2 World Nanopharmaceuticals Production by Region (2019-2030)
        1.3.3 World Nanopharmaceuticals Average Price by Region (2019-2030)
        1.3.4 North America Nanopharmaceuticals Production (2019-2030)
        1.3.5 Europe Nanopharmaceuticals Production (2019-2030)
        1.3.6 China Nanopharmaceuticals Production (2019-2030)
        1.3.7 Japan Nanopharmaceuticals Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Nanopharmaceuticals Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Nanopharmaceuticals Major Market Trends

2 Demand Summary
    2.1 World Nanopharmaceuticals Demand (2019-2030)
    2.2 World Nanopharmaceuticals Consumption by Region
        2.2.1 World Nanopharmaceuticals Consumption by Region (2019-2024)
        2.2.2 World Nanopharmaceuticals Consumption Forecast by Region (2025-2030)
    2.3 United States Nanopharmaceuticals Consumption (2019-2030)
    2.4 China Nanopharmaceuticals Consumption (2019-2030)
    2.5 Europe Nanopharmaceuticals Consumption (2019-2030)
    2.6 Japan Nanopharmaceuticals Consumption (2019-2030)
    2.7 South Korea Nanopharmaceuticals Consumption (2019-2030)
    2.8 ASEAN Nanopharmaceuticals Consumption (2019-2030)
    2.9 India Nanopharmaceuticals Consumption (2019-2030)

3 World Nanopharmaceuticals Manufacturers Competitive Analysis
    3.1 World Nanopharmaceuticals Production Value by Manufacturer (2019-2024)
    3.2 World Nanopharmaceuticals Production by Manufacturer (2019-2024)
    3.3 World Nanopharmaceuticals Average Price by Manufacturer (2019-2024)
    3.4 Nanopharmaceuticals Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Nanopharmaceuticals Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Nanopharmaceuticals in 2023
        3.5.3 Global Concentration Ratios (CR8) for Nanopharmaceuticals in 2023
    3.6 Nanopharmaceuticals Market: Overall Company Footprint Analysis
        3.6.1 Nanopharmaceuticals Market: Region Footprint
        3.6.2 Nanopharmaceuticals Market: Company Product Type Footprint
        3.6.3 Nanopharmaceuticals Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Nanopharmaceuticals Production Value Comparison
        4.1.1 United States VS China: Nanopharmaceuticals Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Nanopharmaceuticals Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Nanopharmaceuticals Production Comparison
        4.2.1 United States VS China: Nanopharmaceuticals Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Nanopharmaceuticals Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Nanopharmaceuticals Consumption Comparison
        4.3.1 United States VS China: Nanopharmaceuticals Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Nanopharmaceuticals Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Nanopharmaceuticals Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Nanopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Nanopharmaceuticals Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Nanopharmaceuticals Production (2019-2024)
    4.5 China Based Nanopharmaceuticals Manufacturers and Market Share
        4.5.1 China Based Nanopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Nanopharmaceuticals Production Value (2019-2024)
        4.5.3 China Based Manufacturers Nanopharmaceuticals Production (2019-2024)
    4.6 Rest of World Based Nanopharmaceuticals Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Nanopharmaceuticals Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Nanopharmaceuticals Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Nanopharmaceuticals Production (2019-2024)

5 Market Analysis by Type
    5.1 World Nanopharmaceuticals Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Liposomes
        5.2.2 Polymeric Micelles
        5.2.3 Solid Lipid Nanoparticles
        5.2.4 Microemulsion and Nnanoemulsion
        5.2.5 Nanosuspension
    5.3 Market Segment by Type
        5.3.1 World Nanopharmaceuticals Production by Type (2019-2030)
        5.3.2 World Nanopharmaceuticals Production Value by Type (2019-2030)
        5.3.3 World Nanopharmaceuticals Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Nanopharmaceuticals Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Cancer and Tumor
        6.2.2 Autoimmune Disorders
        6.2.3 Inflammation
        6.2.4 Others
    6.3 Market Segment by Application
        6.3.1 World Nanopharmaceuticals Production by Application (2019-2030)
        6.3.2 World Nanopharmaceuticals Production Value by Application (2019-2030)
        6.3.3 World Nanopharmaceuticals Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Merck
        7.1.1 Merck Details
        7.1.2 Merck Major Business
        7.1.3 Merck Nanopharmaceuticals Product and Services
        7.1.4 Merck Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Merck Recent Developments/Updates
        7.1.6 Merck Competitive Strengths & Weaknesses
    7.2 Pfizer
        7.2.1 Pfizer Details
        7.2.2 Pfizer Major Business
        7.2.3 Pfizer Nanopharmaceuticals Product and Services
        7.2.4 Pfizer Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Pfizer Recent Developments/Updates
        7.2.6 Pfizer Competitive Strengths & Weaknesses
    7.3 Novartis
        7.3.1 Novartis Details
        7.3.2 Novartis Major Business
        7.3.3 Novartis Nanopharmaceuticals Product and Services
        7.3.4 Novartis Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Novartis Recent Developments/Updates
        7.3.6 Novartis Competitive Strengths & Weaknesses
    7.4 Abbott
        7.4.1 Abbott Details
        7.4.2 Abbott Major Business
        7.4.3 Abbott Nanopharmaceuticals Product and Services
        7.4.4 Abbott Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Abbott Recent Developments/Updates
        7.4.6 Abbott Competitive Strengths & Weaknesses
    7.5 GlaxoSmithKline
        7.5.1 GlaxoSmithKline Details
        7.5.2 GlaxoSmithKline Major Business
        7.5.3 GlaxoSmithKline Nanopharmaceuticals Product and Services
        7.5.4 GlaxoSmithKline Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 GlaxoSmithKline Recent Developments/Updates
        7.5.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.6 Roche
        7.6.1 Roche Details
        7.6.2 Roche Major Business
        7.6.3 Roche Nanopharmaceuticals Product and Services
        7.6.4 Roche Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Roche Recent Developments/Updates
        7.6.6 Roche Competitive Strengths & Weaknesses
    7.7 Sanofi
        7.7.1 Sanofi Details
        7.7.2 Sanofi Major Business
        7.7.3 Sanofi Nanopharmaceuticals Product and Services
        7.7.4 Sanofi Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Sanofi Recent Developments/Updates
        7.7.6 Sanofi Competitive Strengths & Weaknesses
    7.8 Eli Lilly
        7.8.1 Eli Lilly Details
        7.8.2 Eli Lilly Major Business
        7.8.3 Eli Lilly Nanopharmaceuticals Product and Services
        7.8.4 Eli Lilly Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Eli Lilly Recent Developments/Updates
        7.8.6 Eli Lilly Competitive Strengths & Weaknesses
    7.9 Astrazeneca
        7.9.1 Astrazeneca Details
        7.9.2 Astrazeneca Major Business
        7.9.3 Astrazeneca Nanopharmaceuticals Product and Services
        7.9.4 Astrazeneca Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Astrazeneca Recent Developments/Updates
        7.9.6 Astrazeneca Competitive Strengths & Weaknesses
    7.10 Johnson & Johnson
        7.10.1 Johnson & Johnson Details
        7.10.2 Johnson & Johnson Major Business
        7.10.3 Johnson & Johnson Nanopharmaceuticals Product and Services
        7.10.4 Johnson & Johnson Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Johnson & Johnson Recent Developments/Updates
        7.10.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.11 Celgene
        7.11.1 Celgene Details
        7.11.2 Celgene Major Business
        7.11.3 Celgene Nanopharmaceuticals Product and Services
        7.11.4 Celgene Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Celgene Recent Developments/Updates
        7.11.6 Celgene Competitive Strengths & Weaknesses
    7.12 Novavax
        7.12.1 Novavax Details
        7.12.2 Novavax Major Business
        7.12.3 Novavax Nanopharmaceuticals Product and Services
        7.12.4 Novavax Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Novavax Recent Developments/Updates
        7.12.6 Novavax Competitive Strengths & Weaknesses
    7.13 Stryker
        7.13.1 Stryker Details
        7.13.2 Stryker Major Business
        7.13.3 Stryker Nanopharmaceuticals Product and Services
        7.13.4 Stryker Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Stryker Recent Developments/Updates
        7.13.6 Stryker Competitive Strengths & Weaknesses
    7.14 Gilead Sciences
        7.14.1 Gilead Sciences Details
        7.14.2 Gilead Sciences Major Business
        7.14.3 Gilead Sciences Nanopharmaceuticals Product and Services
        7.14.4 Gilead Sciences Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 Gilead Sciences Recent Developments/Updates
        7.14.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.15 OSI Pharmaceuticals
        7.15.1 OSI Pharmaceuticals Details
        7.15.2 OSI Pharmaceuticals Major Business
        7.15.3 OSI Pharmaceuticals Nanopharmaceuticals Product and Services
        7.15.4 OSI Pharmaceuticals Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.15.5 OSI Pharmaceuticals Recent Developments/Updates
        7.15.6 OSI Pharmaceuticals Competitive Strengths & Weaknesses
    7.16 Kadmon Pharmaceuticals
        7.16.1 Kadmon Pharmaceuticals Details
        7.16.2 Kadmon Pharmaceuticals Major Business
        7.16.3 Kadmon Pharmaceuticals Nanopharmaceuticals Product and Services
        7.16.4 Kadmon Pharmaceuticals Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.16.5 Kadmon Pharmaceuticals Recent Developments/Updates
        7.16.6 Kadmon Pharmaceuticals Competitive Strengths & Weaknesses
    7.17 Samyang Biopharm
        7.17.1 Samyang Biopharm Details
        7.17.2 Samyang Biopharm Major Business
        7.17.3 Samyang Biopharm Nanopharmaceuticals Product and Services
        7.17.4 Samyang Biopharm Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.17.5 Samyang Biopharm Recent Developments/Updates
        7.17.6 Samyang Biopharm Competitive Strengths & Weaknesses
    7.18 Mitsubishi Pharma
        7.18.1 Mitsubishi Pharma Details
        7.18.2 Mitsubishi Pharma Major Business
        7.18.3 Mitsubishi Pharma Nanopharmaceuticals Product and Services
        7.18.4 Mitsubishi Pharma Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.18.5 Mitsubishi Pharma Recent Developments/Updates
        7.18.6 Mitsubishi Pharma Competitive Strengths & Weaknesses
    7.19 Kaken Pharmaceutical
        7.19.1 Kaken Pharmaceutical Details
        7.19.2 Kaken Pharmaceutical Major Business
        7.19.3 Kaken Pharmaceutical Nanopharmaceuticals Product and Services
        7.19.4 Kaken Pharmaceutical Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.19.5 Kaken Pharmaceutical Recent Developments/Updates
        7.19.6 Kaken Pharmaceutical Competitive Strengths & Weaknesses
    7.20 Selecta Biosciences
        7.20.1 Selecta Biosciences Details
        7.20.2 Selecta Biosciences Major Business
        7.20.3 Selecta Biosciences Nanopharmaceuticals Product and Services
        7.20.4 Selecta Biosciences Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.20.5 Selecta Biosciences Recent Developments/Updates
        7.20.6 Selecta Biosciences Competitive Strengths & Weaknesses
    7.21 Par Pharmaceutical
        7.21.1 Par Pharmaceutical Details
        7.21.2 Par Pharmaceutical Major Business
        7.21.3 Par Pharmaceutical Nanopharmaceuticals Product and Services
        7.21.4 Par Pharmaceutical Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.21.5 Par Pharmaceutical Recent Developments/Updates
        7.21.6 Par Pharmaceutical Competitive Strengths & Weaknesses
    7.22 Cerulean Pharma
        7.22.1 Cerulean Pharma Details
        7.22.2 Cerulean Pharma Major Business
        7.22.3 Cerulean Pharma Nanopharmaceuticals Product and Services
        7.22.4 Cerulean Pharma Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.22.5 Cerulean Pharma Recent Developments/Updates
        7.22.6 Cerulean Pharma Competitive Strengths & Weaknesses
    7.23 Navidea Biopharmaceuticals
        7.23.1 Navidea Biopharmaceuticals Details
        7.23.2 Navidea Biopharmaceuticals Major Business
        7.23.3 Navidea Biopharmaceuticals Nanopharmaceuticals Product and Services
        7.23.4 Navidea Biopharmaceuticals Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.23.5 Navidea Biopharmaceuticals Recent Developments/Updates
        7.23.6 Navidea Biopharmaceuticals Competitive Strengths & Weaknesses
    7.24 Lummy
        7.24.1 Lummy Details
        7.24.2 Lummy Major Business
        7.24.3 Lummy Nanopharmaceuticals Product and Services
        7.24.4 Lummy Nanopharmaceuticals Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.24.5 Lummy Recent Developments/Updates
        7.24.6 Lummy Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Nanopharmaceuticals Industry Chain
    8.2 Nanopharmaceuticals Upstream Analysis
        8.2.1 Nanopharmaceuticals Core Raw Materials
        8.2.2 Main Manufacturers of Nanopharmaceuticals Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Nanopharmaceuticals Production Mode
    8.6 Nanopharmaceuticals Procurement Model
    8.7 Nanopharmaceuticals Industry Sales Model and Sales Channels
        8.7.1 Nanopharmaceuticals Sales Model
        8.7.2 Nanopharmaceuticals Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Nanopharmaceuticals Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Nanopharmaceuticals Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Nanopharmaceuticals Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Nanopharmaceuticals Production Value Market Share by Region (2019-2024)
    Table 5. World Nanopharmaceuticals Production Value Market Share by Region (2025-2030)
    Table 6. World Nanopharmaceuticals Production by Region (2019-2024) & (K MT)
    Table 7. World Nanopharmaceuticals Production by Region (2025-2030) & (K MT)
    Table 8. World Nanopharmaceuticals Production Market Share by Region (2019-2024)
    Table 9. World Nanopharmaceuticals Production Market Share by Region (2025-2030)
    Table 10. World Nanopharmaceuticals Average Price by Region (2019-2024) & (USD/MT)
    Table 11. World Nanopharmaceuticals Average Price by Region (2025-2030) & (USD/MT)
    Table 12. Nanopharmaceuticals Major Market Trends
    Table 13. World Nanopharmaceuticals Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K MT)
    Table 14. World Nanopharmaceuticals Consumption by Region (2019-2024) & (K MT)
    Table 15. World Nanopharmaceuticals Consumption Forecast by Region (2025-2030) & (K MT)
    Table 16. World Nanopharmaceuticals Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Nanopharmaceuticals Producers in 2023
    Table 18. World Nanopharmaceuticals Production by Manufacturer (2019-2024) & (K MT)
    Table 19. Production Market Share of Key Nanopharmaceuticals Producers in 2023
    Table 20. World Nanopharmaceuticals Average Price by Manufacturer (2019-2024) & (USD/MT)
    Table 21. Global Nanopharmaceuticals Company Evaluation Quadrant
    Table 22. World Nanopharmaceuticals Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Nanopharmaceuticals Production Site of Key Manufacturer
    Table 24. Nanopharmaceuticals Market: Company Product Type Footprint
    Table 25. Nanopharmaceuticals Market: Company Product Application Footprint
    Table 26. Nanopharmaceuticals Competitive Factors
    Table 27. Nanopharmaceuticals New Entrant and Capacity Expansion Plans
    Table 28. Nanopharmaceuticals Mergers & Acquisitions Activity
    Table 29. United States VS China Nanopharmaceuticals Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Nanopharmaceuticals Production Comparison, (2019 & 2023 & 2030) & (K MT)
    Table 31. United States VS China Nanopharmaceuticals Consumption Comparison, (2019 & 2023 & 2030) & (K MT)
    Table 32. United States Based Nanopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Nanopharmaceuticals Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Nanopharmaceuticals Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Nanopharmaceuticals Production (2019-2024) & (K MT)
    Table 36. United States Based Manufacturers Nanopharmaceuticals Production Market Share (2019-2024)
    Table 37. China Based Nanopharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Nanopharmaceuticals Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Nanopharmaceuticals Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Nanopharmaceuticals Production (2019-2024) & (K MT)
    Table 41. China Based Manufacturers Nanopharmaceuticals Production Market Share (2019-2024)
    Table 42. Rest of World Based Nanopharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Nanopharmaceuticals Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Nanopharmaceuticals Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Nanopharmaceuticals Production (2019-2024) & (K MT)
    Table 46. Rest of World Based Manufacturers Nanopharmaceuticals Production Market Share (2019-2024)
    Table 47. World Nanopharmaceuticals Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Nanopharmaceuticals Production by Type (2019-2024) & (K MT)
    Table 49. World Nanopharmaceuticals Production by Type (2025-2030) & (K MT)
    Table 50. World Nanopharmaceuticals Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Nanopharmaceuticals Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Nanopharmaceuticals Average Price by Type (2019-2024) & (USD/MT)
    Table 53. World Nanopharmaceuticals Average Price by Type (2025-2030) & (USD/MT)
    Table 54. World Nanopharmaceuticals Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Nanopharmaceuticals Production by Application (2019-2024) & (K MT)
    Table 56. World Nanopharmaceuticals Production by Application (2025-2030) & (K MT)
    Table 57. World Nanopharmaceuticals Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Nanopharmaceuticals Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Nanopharmaceuticals Average Price by Application (2019-2024) & (USD/MT)
    Table 60. World Nanopharmaceuticals Average Price by Application (2025-2030) & (USD/MT)
    Table 61. Merck Basic Information, Manufacturing Base and Competitors
    Table 62. Merck Major Business
    Table 63. Merck Nanopharmaceuticals Product and Services
    Table 64. Merck Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Merck Recent Developments/Updates
    Table 66. Merck Competitive Strengths & Weaknesses
    Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 68. Pfizer Major Business
    Table 69. Pfizer Nanopharmaceuticals Product and Services
    Table 70. Pfizer Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Pfizer Recent Developments/Updates
    Table 72. Pfizer Competitive Strengths & Weaknesses
    Table 73. Novartis Basic Information, Manufacturing Base and Competitors
    Table 74. Novartis Major Business
    Table 75. Novartis Nanopharmaceuticals Product and Services
    Table 76. Novartis Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Novartis Recent Developments/Updates
    Table 78. Novartis Competitive Strengths & Weaknesses
    Table 79. Abbott Basic Information, Manufacturing Base and Competitors
    Table 80. Abbott Major Business
    Table 81. Abbott Nanopharmaceuticals Product and Services
    Table 82. Abbott Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Abbott Recent Developments/Updates
    Table 84. Abbott Competitive Strengths & Weaknesses
    Table 85. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 86. GlaxoSmithKline Major Business
    Table 87. GlaxoSmithKline Nanopharmaceuticals Product and Services
    Table 88. GlaxoSmithKline Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. GlaxoSmithKline Recent Developments/Updates
    Table 90. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 91. Roche Basic Information, Manufacturing Base and Competitors
    Table 92. Roche Major Business
    Table 93. Roche Nanopharmaceuticals Product and Services
    Table 94. Roche Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Roche Recent Developments/Updates
    Table 96. Roche Competitive Strengths & Weaknesses
    Table 97. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 98. Sanofi Major Business
    Table 99. Sanofi Nanopharmaceuticals Product and Services
    Table 100. Sanofi Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Sanofi Recent Developments/Updates
    Table 102. Sanofi Competitive Strengths & Weaknesses
    Table 103. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 104. Eli Lilly Major Business
    Table 105. Eli Lilly Nanopharmaceuticals Product and Services
    Table 106. Eli Lilly Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Eli Lilly Recent Developments/Updates
    Table 108. Eli Lilly Competitive Strengths & Weaknesses
    Table 109. Astrazeneca Basic Information, Manufacturing Base and Competitors
    Table 110. Astrazeneca Major Business
    Table 111. Astrazeneca Nanopharmaceuticals Product and Services
    Table 112. Astrazeneca Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. Astrazeneca Recent Developments/Updates
    Table 114. Astrazeneca Competitive Strengths & Weaknesses
    Table 115. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 116. Johnson & Johnson Major Business
    Table 117. Johnson & Johnson Nanopharmaceuticals Product and Services
    Table 118. Johnson & Johnson Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. Johnson & Johnson Recent Developments/Updates
    Table 120. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 121. Celgene Basic Information, Manufacturing Base and Competitors
    Table 122. Celgene Major Business
    Table 123. Celgene Nanopharmaceuticals Product and Services
    Table 124. Celgene Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 125. Celgene Recent Developments/Updates
    Table 126. Celgene Competitive Strengths & Weaknesses
    Table 127. Novavax Basic Information, Manufacturing Base and Competitors
    Table 128. Novavax Major Business
    Table 129. Novavax Nanopharmaceuticals Product and Services
    Table 130. Novavax Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 131. Novavax Recent Developments/Updates
    Table 132. Novavax Competitive Strengths & Weaknesses
    Table 133. Stryker Basic Information, Manufacturing Base and Competitors
    Table 134. Stryker Major Business
    Table 135. Stryker Nanopharmaceuticals Product and Services
    Table 136. Stryker Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 137. Stryker Recent Developments/Updates
    Table 138. Stryker Competitive Strengths & Weaknesses
    Table 139. Gilead Sciences Basic Information, Manufacturing Base and Competitors
    Table 140. Gilead Sciences Major Business
    Table 141. Gilead Sciences Nanopharmaceuticals Product and Services
    Table 142. Gilead Sciences Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 143. Gilead Sciences Recent Developments/Updates
    Table 144. Gilead Sciences Competitive Strengths & Weaknesses
    Table 145. OSI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 146. OSI Pharmaceuticals Major Business
    Table 147. OSI Pharmaceuticals Nanopharmaceuticals Product and Services
    Table 148. OSI Pharmaceuticals Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 149. OSI Pharmaceuticals Recent Developments/Updates
    Table 150. OSI Pharmaceuticals Competitive Strengths & Weaknesses
    Table 151. Kadmon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 152. Kadmon Pharmaceuticals Major Business
    Table 153. Kadmon Pharmaceuticals Nanopharmaceuticals Product and Services
    Table 154. Kadmon Pharmaceuticals Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 155. Kadmon Pharmaceuticals Recent Developments/Updates
    Table 156. Kadmon Pharmaceuticals Competitive Strengths & Weaknesses
    Table 157. Samyang Biopharm Basic Information, Manufacturing Base and Competitors
    Table 158. Samyang Biopharm Major Business
    Table 159. Samyang Biopharm Nanopharmaceuticals Product and Services
    Table 160. Samyang Biopharm Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 161. Samyang Biopharm Recent Developments/Updates
    Table 162. Samyang Biopharm Competitive Strengths & Weaknesses
    Table 163. Mitsubishi Pharma Basic Information, Manufacturing Base and Competitors
    Table 164. Mitsubishi Pharma Major Business
    Table 165. Mitsubishi Pharma Nanopharmaceuticals Product and Services
    Table 166. Mitsubishi Pharma Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 167. Mitsubishi Pharma Recent Developments/Updates
    Table 168. Mitsubishi Pharma Competitive Strengths & Weaknesses
    Table 169. Kaken Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 170. Kaken Pharmaceutical Major Business
    Table 171. Kaken Pharmaceutical Nanopharmaceuticals Product and Services
    Table 172. Kaken Pharmaceutical Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 173. Kaken Pharmaceutical Recent Developments/Updates
    Table 174. Kaken Pharmaceutical Competitive Strengths & Weaknesses
    Table 175. Selecta Biosciences Basic Information, Manufacturing Base and Competitors
    Table 176. Selecta Biosciences Major Business
    Table 177. Selecta Biosciences Nanopharmaceuticals Product and Services
    Table 178. Selecta Biosciences Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 179. Selecta Biosciences Recent Developments/Updates
    Table 180. Selecta Biosciences Competitive Strengths & Weaknesses
    Table 181. Par Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 182. Par Pharmaceutical Major Business
    Table 183. Par Pharmaceutical Nanopharmaceuticals Product and Services
    Table 184. Par Pharmaceutical Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 185. Par Pharmaceutical Recent Developments/Updates
    Table 186. Par Pharmaceutical Competitive Strengths & Weaknesses
    Table 187. Cerulean Pharma Basic Information, Manufacturing Base and Competitors
    Table 188. Cerulean Pharma Major Business
    Table 189. Cerulean Pharma Nanopharmaceuticals Product and Services
    Table 190. Cerulean Pharma Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 191. Cerulean Pharma Recent Developments/Updates
    Table 192. Cerulean Pharma Competitive Strengths & Weaknesses
    Table 193. Navidea Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 194. Navidea Biopharmaceuticals Major Business
    Table 195. Navidea Biopharmaceuticals Nanopharmaceuticals Product and Services
    Table 196. Navidea Biopharmaceuticals Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 197. Navidea Biopharmaceuticals Recent Developments/Updates
    Table 198. Lummy Basic Information, Manufacturing Base and Competitors
    Table 199. Lummy Major Business
    Table 200. Lummy Nanopharmaceuticals Product and Services
    Table 201. Lummy Nanopharmaceuticals Production (K MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 202. Global Key Players of Nanopharmaceuticals Upstream (Raw Materials)
    Table 203. Nanopharmaceuticals Typical Customers
    Table 204. Nanopharmaceuticals Typical Distributors
List of Figure
    Figure 1. Nanopharmaceuticals Picture
    Figure 2. World Nanopharmaceuticals Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Nanopharmaceuticals Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Nanopharmaceuticals Production (2019-2030) & (K MT)
    Figure 5. World Nanopharmaceuticals Average Price (2019-2030) & (USD/MT)
    Figure 6. World Nanopharmaceuticals Production Value Market Share by Region (2019-2030)
    Figure 7. World Nanopharmaceuticals Production Market Share by Region (2019-2030)
    Figure 8. North America Nanopharmaceuticals Production (2019-2030) & (K MT)
    Figure 9. Europe Nanopharmaceuticals Production (2019-2030) & (K MT)
    Figure 10. China Nanopharmaceuticals Production (2019-2030) & (K MT)
    Figure 11. Japan Nanopharmaceuticals Production (2019-2030) & (K MT)
    Figure 12. Nanopharmaceuticals Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Nanopharmaceuticals Consumption (2019-2030) & (K MT)
    Figure 15. World Nanopharmaceuticals Consumption Market Share by Region (2019-2030)
    Figure 16. United States Nanopharmaceuticals Consumption (2019-2030) & (K MT)
    Figure 17. China Nanopharmaceuticals Consumption (2019-2030) & (K MT)
    Figure 18. Europe Nanopharmaceuticals Consumption (2019-2030) & (K MT)
    Figure 19. Japan Nanopharmaceuticals Consumption (2019-2030) & (K MT)
    Figure 20. South Korea Nanopharmaceuticals Consumption (2019-2030) & (K MT)
    Figure 21. ASEAN Nanopharmaceuticals Consumption (2019-2030) & (K MT)
    Figure 22. India Nanopharmaceuticals Consumption (2019-2030) & (K MT)
    Figure 23. Producer Shipments of Nanopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Nanopharmaceuticals Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Nanopharmaceuticals Markets in 2023
    Figure 26. United States VS China: Nanopharmaceuticals Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Nanopharmaceuticals Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Nanopharmaceuticals Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Nanopharmaceuticals Production Market Share 2023
    Figure 30. China Based Manufacturers Nanopharmaceuticals Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Nanopharmaceuticals Production Market Share 2023
    Figure 32. World Nanopharmaceuticals Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Nanopharmaceuticals Production Value Market Share by Type in 2023
    Figure 34. Liposomes
    Figure 35. Polymeric Micelles
    Figure 36. Solid Lipid Nanoparticles
    Figure 37. Microemulsion and Nnanoemulsion
    Figure 38. Nanosuspension
    Figure 39. World Nanopharmaceuticals Production Market Share by Type (2019-2030)
    Figure 40. World Nanopharmaceuticals Production Value Market Share by Type (2019-2030)
    Figure 41. World Nanopharmaceuticals Average Price by Type (2019-2030) & (USD/MT)
    Figure 42. World Nanopharmaceuticals Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 43. World Nanopharmaceuticals Production Value Market Share by Application in 2023
    Figure 44. Cancer and Tumor
    Figure 45. Autoimmune Disorders
    Figure 46. Inflammation
    Figure 47. Others
    Figure 48. World Nanopharmaceuticals Production Market Share by Application (2019-2030)
    Figure 49. World Nanopharmaceuticals Production Value Market Share by Application (2019-2030)
    Figure 50. World Nanopharmaceuticals Average Price by Application (2019-2030) & (USD/MT)
    Figure 51. Nanopharmaceuticals Industry Chain
    Figure 52. Nanopharmaceuticals Procurement Model
    Figure 53. Nanopharmaceuticals Sales Model
    Figure 54. Nanopharmaceuticals Sales Channels, Direct Sales, and Distribution
    Figure 55. Methodology
    Figure 56. Research Process and Data Source

Companies Mentioned

Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy